• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Congruence Joins 25th Needham Virtual Healthcare Conference

    PR NEWSWIRE

    Congruence Doses First Patient in CGX-926 Phase 1/1b Trial

    PR NEWSWIRE

    Congruence Secures $39.5M To Progress Small Molecule Correctors

    PR NEWSWIRE

    Ono Pharma, Congruence Collaborate on Neurology, Immunology

    PHARMIWEB

    Congruence, Ono Pharma Expand Partnership to Two New Targets

    PR NEWSWIRE

    Congruence Therapeutics Unveils CGX-926 For Genetic Obesity

    PR NEWSWIRE

    Congruence Get MJFF Grant to Advance Parkinson`s GCase Activators

    PR NEWSWIRE

    Congruence Present MC4R Corrector CGX-926 for Early-Onset Obesity

    PR NEWSWIRE

    Ono Partners with Congruence for Oncology Drug Discovery

    PR NEWSWIRE

    Congruence, Ono Partner for Cancer Small Molecule Correctors

    PR NEWSWIRE

    Congruence Appoints Experienced Drug Developer Michael as CDO

    PR NEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.